(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 2.4% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Quidelortho's revenue in 2025 is $2,741,600,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2025 to be $187,133,684,296, with the lowest QDEL revenue forecast at $179,053,528,842, and the highest QDEL revenue forecast at $194,059,531,828. On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $192,090,418,314, with the lowest QDEL revenue forecast at $182,109,049,812, and the highest QDEL revenue forecast at $201,189,080,758.
In 2027, QDEL is forecast to generate $200,577,976,564 in revenue, with the lowest revenue forecast at $190,257,105,732 and the highest revenue forecast at $210,423,544,134.